The detection of tumor suppressor gene promoter methylation in sputum-derived exfoliated cells predicts early lung cancer. Here we identified genetic determinants for this epigenetic process and examined their biological effects on gene regulation. A two-stage approach involving discovery and replication was employed to assess the association between promoter hypermethylation of a 12-gene panel and common variation in 40 genes involved in carcinogen metabolism, regulation of methylation, and DNA damage response in members of the Lovelace Smokers Cohort (n=1434). Molecular validation of three identified variants was conducted using primary bronchial epithelial cells. Association of study-wide significance (P<8.2×10 -5 ) was identified for rs1641511, rs3730859, and rs1883264 in TP53, LIG1, and BIK, respectively.
Introduction
Lung cancer is the leading cause of cancer-related mortality in both men and women in the United States and occurs largely from chronic exposure to tobacco carcinogens (1) . The development of this disease over 30 to 40 years involves field cancerization, characterized as the acquisition of genetic and epigenetic changes in oncogenes and tumor suppressor genes (TSG) throughout the airway epithelium (2) (3) (4) . The silencing of TSGs through promoter methylation is now recognized as a major and causal epigenetic event that occurs during lung cancer initiation and progression (4) . Genes involved in all aspects of normal cell function that include cell cycle regulation, differentiation, adhesion, and death, are silenced by promoter methylation in lung tumors (4) . Based on the silencing of key TSGs in the lungs of smokers, we hypothesized that the detection of promoter methylation of TSGs in exfoliated cells in sputum would provide an assessment of the extent of field cancerization that in turn may predict early lung cancer. This hypothesis has been validated in several studies (5) (6) (7) , suggesting that gene methylation in sputum could be used as a molecular marker for identifying people at high risk for cancer incidence.
The fact that promoter methylation of TSGs is a promising marker for early detection of lung cancer makes understanding factors that influence the individual susceptibility for this epigenetic process throughout the respiratory epithelium a high priority. The precise mechanism by which carcinogens disrupt the capacity of cells to maintain the epigenetic code during DNA replication and repair is largely unknown. Carcinogens within tobacco induce single-and double-strand DNA breaks which, if left unrepaired or if mis-repaired, lead to mutagenic and/or carcinogenic changes in cells (8) . Accumulating evidence from our group and others suggests that extensive DNA damage could also be responsible for acquisition of promoter methylation of Author Manuscript Published OnlineFirst on December 2, 2011; DOI: 10.1158/0008-5472. TSGs during lung carcinogenesis. Support for this supposition was provided through several recent studies from our group (9) (10) (11) (12) . A highly significant association was observed between DNA repair capacity (DRC) for double strand breaks measured in lymphocytes and the propensity for gene methylation detected in sputum from cancer-free smokers from the Lovelace Smokers Cohort (LSC) (9) . A subsequent study in the same cohort identified the dietary factors including folate, leafy green vegetables, and multivitamin use as protective against the acquisition of gene methylation possibly through the modulation of DRC and/or the reduction of DNA damage induced by tobacco-derived carcinogens due to their anti-oxidative effect (10) .
Chronic exposure of human bronchial epithelial cells to non-cytotoxic levels of tobacco-derived carcinogens induced de novo methylation of TSGs, epithelial-to-mesenchymal transition, and eventually transformation (11) . Cuozzo et al. (12) provides a mechanistic link between DNA damage and methylation by demonstrating activation of homologous recombination following introduction of a double strand break and subsequent methylation of the recombinant gene.
Together, these studies suggest that chronic DNA damage and reduced DRC could be important determinants for inducing gene methylation.
Several sequence patterns within gene promoters that contain CpG islands and embryonic targets of polycomb-repressive complex 2 are predictive for gene predisposition for methylation in cancer, but cannot discriminate the inter-individual susceptibility for gene silencing (13) (14) (15) (16) (17) .
Sequence variants in promoters associated with reduced gene transcription lead to allele-specific methylation (ASM) and silencing in glutathione S-transferase pi (GSTP1) and O 6 -methylguanine-DNA methyltransferase (MGMT) in tumors and premalignant tissues (18,19).
Mechanisms independent of effects on gene transcription were also identified for ASM of the reversion-induced LIM gene (20) . Several studies conducting chromosome-wide or genome- wide surveys on non-imprinted, autosomal regions in human lymphocytes suggest that the majority of TSGs are not silenced by sequence variant dependent ASM (21,22). Based on the likelihood that DNA damage induced by tobacco carcinogens is an important step in the acquisition of de novo methylation and that reduced carcinogen detoxification and DRC have been associated with lung cancer (9) (10) (11) (12) ,23), we tested the hypothesis that genetic variation in some genes involved in these pathways are associated with susceptibility for smokers to acquire gene-specific promoter methylation detected in sputum that contains exfoliated lung cells. A two-stage approach involving discovery and replication was employed to assess the association between promoter methylation of a 12-gene panel in members of the LSC and common variation in 40 genes involved in carcinogen metabolism, regulation of methylation, and DNA damage response, the latter including DNA damage repair, cell cycle regulation, and apoptosis.
Molecular validation of significant variants was conducted using primary bronchial epithelial cell cultures. longitudinal studies on molecular markers of respiratory carcinogenesis in biological fluids such as sputum from people at risk for lung cancer (9) . The enrollment initially focused on female smokers and was expanded to include male smokers in 2004. Enrollment was restricted to current and former smokers age 40 to 74 y with a minimum of 20 pack-years of smoking.
Detailed information regarding sample collection was described in Supplementary Materials and Methods. All participants signed a consent form, and the Western Institutional Review Board approved this project.
Methylation of a 12-gene panel was successfully assessed in cytological adequate sputum samples from 1434 cohort members who are either Caucasian or Hispanic and for whom the genotyping call rate was 75%. Members with other ethnicities were not included in this study because of their low representation in the LSC (overall < 6%). Cohort members were split into two populations for the discovery (n=713) and replication (n=721) based on their methylation index and several non-genetic risk factors for gene methylation including gender, ethnicity, current smoking status, and age at enrollment (10) . The demographic characteristics for the cohort members in the discovery and replication stages are shown in Table 1 .
Sputum Processing and Gene Promoter Methylation.
A detailed procedure for sputum collection and processing has been described (10) . Briefly, sputum samples were stored in Saccomanno's fixative. Sputum adequacy, defined as the presence of deep lung macrophages or Curschmann's spiral (7) , was assessed by a pathologist. Twelve genes were selected for analysis of methylation in sputum based on our previous studies establishing their association with risk for lung cancer and their specificity to methylation in epithelial cells (5) (6) (7) . These twelve genes Author Manuscript Published OnlineFirst on December 2, 2011; DOI: 10.1158/0008-5472. had to pass the replication stage with P < 0.05. The SNPs that satisfied the criteria for both the discovery and replication stages also were analyzed with the combined data set. A Bonferroni adjustment over all SNPs included in the analysis (n=600) was used (P=8.2 x 10 -5 ).
The methylation index based on a 12-gene panel is a discrete count variable defined as the number of genes in the panel that are methylated and ranges from 0 to 10 in the LSC ( Figure   1 ). Poisson regression was conducted to examine the association between the independent variables, the SNPs/haplotypes, and the outcome variable, the methylation index, with adjustment for covariates selected a priori that include age, gender, ethnicity, current smoking status, and packyears. The additive model was tested for each SNP; and common homozygotes, heterozygotes, and rare homozygotes were coded as 0, 1, and 2, respectively. The Poisson regression model is a generalized linear model that can be used to estimate the mean frequency ratio (FR) and its 95% confidence interval. The FR was calculated from the regression coefficient for an explanatory variable in the Poisson regression model, ȕ, through the equation MAF, a dominant model that combines variant homozygotes and heterozygotes was applied and the difference between the two genotype groups was compared using the student t test. The statistical analyses were conducted using SAS software, version 9.2 (SAS Institute, Cary, NC). 
Results
Association between individual SNPs and methylation index. Individual SNP association analysis identified 109 SNPs associated with the methylation index with P value < 0.10 in the discovery stage (Table 2 ; not shown). These 109 SNPs were then analyzed in the replication stage. Eleven SNPs in LIG1, TP53, BIK, BMF, and BAK1 were associated with methylation index with P 0.05 in the replication stage ( Table 2 ). Seven of these 11 SNPs were tag SNPs in LIG1. Combined analysis showed that the overall P value for three SNPs including rs1641511, rs3730859, and rs1883264 reached study-wide significance (Bonferroni corrected P = 8.2×10 -5 Figure 1A , available online). Six haplotype tagging SNPs (htSNPs) including rs11564509, rs251692, rs3730859, rs3730895, rs4802436, and rs972800 allowed the construction of the four common haplotype alleles with minimal R h 2 over 0.82 in both Caucasians and Hispanics (24) . These six htSNPs accounted for > 84% of the haplotype variation in the LIG1 block in Caucasians and Hispanics in the LSC ( 
Discussion
This is the first study to comprehensively evaluate the relationship between methylation index in a large population of lung-cancer free smokers and common variation in 40 candidate genes involved in carcinogen metabolism, regulation of methylation, and DNA damage response pathways. Our findings support a role for genetic variation in LIG1, TP53, and BIK as predictors for the acquisition of gene promoter methylation in exfoliated cells in smokers' sputum.
Specifically, molecular validation through a genotype -expression correlation analysis indicates that the three most significant SNPs in LIG1, TP53, and BIK affect the expression of these three genes in cis in NHBECs. Thus, genetic variation in genes affecting DNA replication and apoptosis impacts the propensity for gene promoter methylation in the aerodigestive tract of smokers and this effect may be driven by the change in the endogenous expression of LIG1, TP53, and BIK.
Epigenetic silencing of TSGs in lung cells is an intermediate biomarker for lung cancer.
Therefore, genetic variation that is strongly associated with epigenetic silencing of TSGs should also impact the risk for lung cancer. Indeed, this premise is supported by studies that systematically assessed the association between tag SNPs in LIG1 and risk for lung cancer (33) (34) (35) (36) . The criteria for selecting these studies to be summarized include large samples size (>500 pairs cases and controls), Caucasian ethnicity, pathway or genome wide association studies, and adequate SNP coverage in LIG1. These criteria were set to minimize the confounding from the publication bias and to ensure inclusion of the sufficiently powered studies. Only association with lung cancer in moderate and heavy smokers (current or former) was presented because over Together, these studies support a moderate association for rs3730859 in LIG1 with risk for the smoking-induced lung cancer and this effect may be mediated by its affect on the predisposition for epigenetic silencing of TSGs.
Among the three DNA ligase families (LIG1, LIG3, and LIG4) in vertebrates, LIG1 plays an essential role in the joining of Okazaki fragments during lagging strand synthesis and is also implicated in multiple DNA repair pathways, although the role of LIG1 in DNA repair can be substituted by other DNA ligases (37) (38) (39) (40) . Deficiency in LIG1 expression results in the delayed joining of Okazaki fragments, genome instability, and increased incidence of epithelial cancers and lymphoma (37) (38) (39) (40) to that in paired distant normal tissues providing further support for a functional deficiency of this gene in lung carcinogenesis (P=0.028, Leng unpublished). The strong association between genetic variation in LIG1 and methylation index found in this study provides in vivo evidence that incomplete loss of LIG1 function due to SNPs could promote the epigenetic silencing of TSGs which in turn contributes to the epithelial carcinogenesis. The mechanism for the effect of LIG1 deficiency on gene methylation is unclear. A recent study found that the replication defect in 46BR.1G1 cells which are homozygote for the Arg771Trp mutation and retain only 3 to 5% of normal LIG1 activity results in the generation of endogenous single-and double-stranded DNA breaks during S phase (40) . These DNA breaks behind the replication fork induce a persistent activation of the ATM/CHK2 pathway without triggering the S-phase-specific DNA damage checkpoint and lead to an altered chromatin structure needed for efficient processing of the DNA damage throughout the cell cycle. Thus, the replication timing could be disrupted in cells with LIG1 deficiency because of the inefficient joining of Okazaki fragments in newly synthesized DNA and the extensively altered chromatin structure. This may be a mechanism by which the guidance of the cytosine-DNA methytransferase to regions that are to be methylated is disrupted during DNA replication and the normally unmethylated regions of DNA become aberrantly methylated (41) . Although such a scenario is clearly speculative, an in vitro malignant transformation model or in vivo tumorigenesis model using LIG1 knock out human epithelial cells or animals could be used to directly test this hypothesis.
Evading apoptosis is a hallmark of cancer and occurs during the progression from premalignant lesions to carcinoma in the lung (42) . Apoptosis occurs through two mechanisms: the death receptor FAS/FAS ligand (also called extrinsic) pathway and the mitochondrial (DNA damage-induced and p53-mediated, also called intrinsic) pathway (43 
pathway plays a key role in eliminating lung epithelial cells with extensive DNA damage upon carcinogen exposure (43) . Thus, the association between functional SNPs in TP53 and BIK and methylation index support the concept that the TP53 mediated apoptosis pathway could prevent the acquisition of heritable genetic and epigenetic changes through eliminating lung cells with extensive DNA damage. The loss of TP53 function by gene mutation is a common genetic alteration found in human cancers and over 50% of lung cancer cases carry somatic mutation of TP53 (44). TP53 mutation or reduced level of wild-type TP53 protein was associated with apoptosis suppression during progression from premalignant lesions to carcinoma in the lung (42) . Thus, rs1641511 that was associated with a 40% reduction of TP53 transcription could cancers (5%; 45). Somatic mutations that lead to amino acid changes were also detected in 8% of patients with B cell lymphomas (45). Epigenetic silencing was also proposed as a potential mechanism to silence BIK expression in specific tumor types, although this mechanism was only 0.62 ± 0.31 * Logrithm transformed LIG1 expression was compared across rs3730859 genotypes using the one way ANOVA. A dominant model that combines variant homozygotes and heterozygotes was applied for rs1641511 and rs1883264 and the difference between the two genotype groups was compared using the student t test. † Number in parentheses indicates number of variant homozygotes. ‡ PCNA was used as the endogenous control to calculate the relative quantification of gene expression. The average of gene expression in wild homozygotes was normalized to 100%. §ȕ-Actin was used as the endogenous control to calculate the relative quantification of gene expression. The average of gene expression in wild homozygotes was normalized to 100%. 
